| Specialty Retail Industry | Consumer Discretionary Sector | Mr. Kleber Cesar Silveira Gomes CEO | B3 Exchange | BROFSAACNOR7 ISIN |
| BR Country | - Employees | 17 Apr 2025 Last Dividend | - Last Split | - IPO Date |
Ouro Fino Saúde Animal Participações S.A., headquartered in Cravinhos, Brazil, stands as a pivotal company in the veterinary healthcare sector, primarily serving the Brazilian market. Founded in 1987, originally under the name A.H.N.S.P.E. Empreendimentos e Participações S.A., the company has grown to encompass a broad spectrum of activities including the development, production, and sale of veterinary drugs, vaccines, and assorted products catering to both production and companion animals. The company’s operational framework is divided into three distinct segments: Production Animals, Companion Animals, and International Operations, enabling it to address the comprehensive needs of a diversified clientele in the veterinary domain.
Ouro Fino Saúde Animal provides a wide array of medicines designed to cater to the health needs of production animals like cattle, swine, poultry, sheep, horses, and goats. This range includes anti-inflammatories, antibiotics, anticoccidials, antimastitics (for the treatment of mastitis), ectoparasiticides, endectocides, endoparasiticides, hemoparasiticides (for the treatment of blood parasites), and products specifically formulated for animal reproduction and treatment of various diseases.
The company manufactures vaccines addressing a range of bacterial and viral diseases for both production and companion animals. This notably enhances herd immunity among production animals and safeguards the health of companion animals, contributing significantly to the overall well-being of animals under human care.
Understanding the importance of nutrition in animal health, Ouro Fino Saúde Animal also produces performance-enhancing additives and probiotics. These products are designed to improve animal growth rates, feed efficiency, and overall health, which in turn, supports the productivity and profitability for farmers and animal rearers.
Aside from its proprietary product offering, Ouro Fino Saúde Animal provides manufacturing services to other entities within the veterinary pharmaceutical sector. This encompasses the production of veterinary medicines and health products according to client specifications and standards.
The company also focuses on the health needs of companion animals, particularly dogs and cats, through a range of veterinary solutions. These include anesthetics, sedatives, anti-inflammatory and antibiotic treatments, antimicrobial and dermatological products, ectoparasiticide and endoparasiticide treatments, dermocosmetic items, and otological products designed to address ear conditions.